Xgeva 120mg tablet dose| Apple pharmaceuticals

XGEVA 120MG

Xgeva 120mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases.

XGEVA PRESCRIBED FOR : 

Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer.
Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

XGEVA DOSAGE: 

For adult :

Osteoporosis : 

60mg SC (subcutaneously) once every 6 months
Injection of drug should be done in upper arm, upper thigh or abdomen 

Giant Cell Tumor of bone :
120mg SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen 

Osteolytic Bone Metastases of Solid Tumors : 

120mg subcutaneously every 4 weeks
Injection of drug should be done in upper arm, upper thigh or abdomen.

Hypercalcemia :
Dose of 120mg Xgeva tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen 

Dosage and administration in pediatric :
13 years and older and 45kg or more 

Giant Cell Tumor of bone:
Dose of 120mg Xgeva tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment..

PRECAUTION

Xgeva injection may improve the negative effects of immuno-suppressants.Especially the risk for serious infections may be increased. Inform your doctor of any immuno-suppressive drugs you early consume.
Not to receive any type of vaccination without your doctor's consultation while admonishing denosumab.

DRUG INTERACTION

No formal drug-drug interaction with denosumab during trials.
When interacting with some anticancer drug, orthopedic drugs, vaccines will lead to risk of adverse effects can be increased.

MISSED DOSE 

Take the dose immediately before next dose duration, then left off the missed dose and continue regular schedule. Avoid taking double dose at same time. Please consult the doctor for further information.

For More Information :


Call us : +91-9987711567

Mail to : applepharmaceutical@gmail.com

Domain : https://myapplepharma.com/xgeva-120mg.php

Comments

Post a Comment

Popular posts from this blog

velasof, velasof tablets ,uses - Myapplepharma

VELASOF TABLETS DESCRIPTION : Velasof   is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. DOSAGE BEFORE THE TREATMENT :  Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs.  Velasof   tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of  Velasof ; The usual recommended dose of  Velasof  is, one tablet should be administered orally as a single dose.  Velasof  tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir.. WORKS AS :  This dynamic active moiety is get inserted into HCV RNA with the help of...
Read more

Today peoples are worried about NSLC – Xovoltib 30mg | Myapplepharma

  Xovoltib 30mg Description : Xovoltib 30mg is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 30mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Indication : Xovoltib 30mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. Mechanism : Xovoltib 30mg dose can blocking the activating sites called tyrosine kinases of various proteins within the cell.By stopping these targets, it will target the cancer will shrink.These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. Precautions : Diarrhae: Most normal condition for people administrating this medications to have diarrhea. Certain situation this diarrhea can be serious. Severe diarrhea can c...
Read more

Sprycel 20mg tablet | Apple pharmaceuticals

Image
Sprycel 20mg Description : Sprycel 20mg belongs to oral dual BCR/ABL and Src group of tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukaemia (CML). The main aim of Sprycel , are BCRABL, SRC, Ephrin’s and GFR. Sprycel 20mg is a prescription drug which used under the supervision of doctor. Indication : Sprycel 20mg   is indicated for the treatment of adult patients having chronic myeloid leukaemia. Sprycel 20mg is indicated for the treatment of adult patients having acute lymphoblastic leukaemia. DRUG INTERACTION :  Sprycel 20mg combination with CYP3A4 inducers will reduces Dasatinib plasma concentration. Sprycel 20mg combination with antacids will decrease Dasatinib plasma concentration. Sprycel 20mg combination with H2 antagonists/proton pump inhibitors will decrease Dasatinib plasma concentration. PRECAUTION :  Using of Sprycel will results in Tumor lysis syndrome; maintain sufficient hydration and correct ur...
Read more